86,45 €*
Versandkostenfrei per Post / DHL
Lieferzeit 2-3 Wochen
Lithium is the essential medication for patients with mood disorders. The evidence of its efficacy in maintenance treatment is acknowledged in all major international treatment guidelines for bipolar disorders and, when used correctly, lithium unquestionably produces the most dramatic benefits of any medication in psychopharmacology. This essential guide is written by two international experts in the treatment of mood disorders who have more than 25 years of experience in the use of lithium and have authored numerous scientific articles on lithium.
Lithium is the essential medication for patients with mood disorders. The evidence of its efficacy in maintenance treatment is acknowledged in all major international treatment guidelines for bipolar disorders and, when used correctly, lithium unquestionably produces the most dramatic benefits of any medication in psychopharmacology. This essential guide is written by two international experts in the treatment of mood disorders who have more than 25 years of experience in the use of lithium and have authored numerous scientific articles on lithium.
Michael Bauer, MD, PhD, is Professor of Psychiatry and Executive Chair of the
Department of Psychiatry and Psychotherapy at the Medical Faculty, Technische
Universität Dresden, in Germany, where he is also Physician-in-Chief at the
Psychiatric Hospital and Outpatient Clinics of the University Hospital Carl
Gustav Carus. He received his medical degree from Freie Universität Berlin
School of Medicine and a PhD in molecular biology and biochemistry from Freie
Universität Berlin. He is the editor together with Prof. Paul Grof and Prof
Bruno-Mueller-Oerlinghausen of the definitive scientific textbook "Lithiumin
Neuropsychiatry-The Comprehensive Guide" (from 2006), and has authored and
coauthored more than 400 articles published in peer-reviewed journals,
including The Lancet, Molecular
Psychiatry and The American Journal
of Psychiatry, and books in the field of mood disorders. He is President of
the International Group for the Study of Lithium-Treated Patients (IGSLi),
chairs the World Federation of Societies of Biological Psychiatry's (WFSBP)
Task Force on Treatment Guidelines for Unipolar Depressive Disorders, and is
project coordinator of the National consortium for the German Treatment
Guidelines for Bipolar Disorder, and leads the National Research Network on
Bipolar Disoder "BipoLife". He is Editor-in-Chief of the International Journal of Bipolar Disorders and Pharmacopsychiatry and editor of Der Nervenarzt.
Michael J. Gitlin, M.D. is Professor of
Clinical Psychiatry at the University of California at Los Angeles (UCLA)
School of Medicine. He is currently the Director of the Adult Division in the
Department of Psychiatry, Medical Director of the Neuropsychiatric Behavioral
Health Services and Director of the Mood Disorders Clinic. From 1980 until
2004, he was the Medical Director of the Aftercare Clinic, a research clinic in
schizophrenia. He is the author of many scientific articles and book chapters
as well as four books, including: two editions of a solo authored
psychopharmacology textbook written for nonphysician therapists entitled
"The Psychotherapist's Guide to Psychopharmacology" published by the Free
Press, the coauthor of "Psychotropic Drugs and Women" with Dr. Victoria
Hendrick and the coauthor of "Clinician's Guide to Bipolar Disorder:
Integrating Pharmacology with Psychotherapy", with Dr. David Miklowitz. He
served as Chief of Staff at the Neuropsychiatric Hospital from 1997-1999. Among
his awards are: Distinguished Educator Award in Teaching from the UCLA
Department of Psychiatry (1999), Outstanding Housestaff Teaching Award, 1994
and 2008, Teacher of the Year from the Psychiatric Times in 2002; Dadone
Clinical Teaching award from the Geffen School of Medicine at UCLA in 2010; and
the Leonard Tow Humanism in Medicine award from the Geffen School of Medicine
at UCLA in 2010.
Provides up-to-date guidance on the use of lithium for short- and long-term treatment of mood disorders
Explains the optimal use of lithium in treatment of mania and depression and in suicide prevention
Written by authors with more than 25 years of experience in research and clinical use of lithium
Erscheinungsjahr: | 2016 |
---|---|
Fachbereich: | Toxikologie |
Genre: | Mathematik, Medizin, Naturwissenschaften, Technik |
Rubrik: | Wissenschaften |
Medium: | Buch |
Inhalt: |
xiv
158 S. 2 s/w Illustr. 15 farbige Illustr. 158 p. 17 illus. 15 illus. in color. |
ISBN-13: | 9783319312125 |
ISBN-10: | 331931212X |
Sprache: | Englisch |
Ausstattung / Beilage: | HC runder Rücken kaschiert |
Einband: | Gebunden |
Autor: |
Gitlin, Michael
Bauer, Michael |
Auflage: | 1st ed. 2016 |
Hersteller: |
Springer Nature Switzerland
Springer International Publishing Springer International Publishing AG |
Verantwortliche Person für die EU: | Books on Demand GmbH, In de Tarpen 42, D-22848 Norderstedt, info@bod.de |
Maße: | 241 x 160 x 15 mm |
Von/Mit: | Michael Gitlin (u. a.) |
Erscheinungsdatum: | 27.05.2016 |
Gewicht: | 0,461 kg |
Michael Bauer, MD, PhD, is Professor of Psychiatry and Executive Chair of the
Department of Psychiatry and Psychotherapy at the Medical Faculty, Technische
Universität Dresden, in Germany, where he is also Physician-in-Chief at the
Psychiatric Hospital and Outpatient Clinics of the University Hospital Carl
Gustav Carus. He received his medical degree from Freie Universität Berlin
School of Medicine and a PhD in molecular biology and biochemistry from Freie
Universität Berlin. He is the editor together with Prof. Paul Grof and Prof
Bruno-Mueller-Oerlinghausen of the definitive scientific textbook "Lithiumin
Neuropsychiatry-The Comprehensive Guide" (from 2006), and has authored and
coauthored more than 400 articles published in peer-reviewed journals,
including The Lancet, Molecular
Psychiatry and The American Journal
of Psychiatry, and books in the field of mood disorders. He is President of
the International Group for the Study of Lithium-Treated Patients (IGSLi),
chairs the World Federation of Societies of Biological Psychiatry's (WFSBP)
Task Force on Treatment Guidelines for Unipolar Depressive Disorders, and is
project coordinator of the National consortium for the German Treatment
Guidelines for Bipolar Disorder, and leads the National Research Network on
Bipolar Disoder "BipoLife". He is Editor-in-Chief of the International Journal of Bipolar Disorders and Pharmacopsychiatry and editor of Der Nervenarzt.
Michael J. Gitlin, M.D. is Professor of
Clinical Psychiatry at the University of California at Los Angeles (UCLA)
School of Medicine. He is currently the Director of the Adult Division in the
Department of Psychiatry, Medical Director of the Neuropsychiatric Behavioral
Health Services and Director of the Mood Disorders Clinic. From 1980 until
2004, he was the Medical Director of the Aftercare Clinic, a research clinic in
schizophrenia. He is the author of many scientific articles and book chapters
as well as four books, including: two editions of a solo authored
psychopharmacology textbook written for nonphysician therapists entitled
"The Psychotherapist's Guide to Psychopharmacology" published by the Free
Press, the coauthor of "Psychotropic Drugs and Women" with Dr. Victoria
Hendrick and the coauthor of "Clinician's Guide to Bipolar Disorder:
Integrating Pharmacology with Psychotherapy", with Dr. David Miklowitz. He
served as Chief of Staff at the Neuropsychiatric Hospital from 1997-1999. Among
his awards are: Distinguished Educator Award in Teaching from the UCLA
Department of Psychiatry (1999), Outstanding Housestaff Teaching Award, 1994
and 2008, Teacher of the Year from the Psychiatric Times in 2002; Dadone
Clinical Teaching award from the Geffen School of Medicine at UCLA in 2010; and
the Leonard Tow Humanism in Medicine award from the Geffen School of Medicine
at UCLA in 2010.
Provides up-to-date guidance on the use of lithium for short- and long-term treatment of mood disorders
Explains the optimal use of lithium in treatment of mania and depression and in suicide prevention
Written by authors with more than 25 years of experience in research and clinical use of lithium
Erscheinungsjahr: | 2016 |
---|---|
Fachbereich: | Toxikologie |
Genre: | Mathematik, Medizin, Naturwissenschaften, Technik |
Rubrik: | Wissenschaften |
Medium: | Buch |
Inhalt: |
xiv
158 S. 2 s/w Illustr. 15 farbige Illustr. 158 p. 17 illus. 15 illus. in color. |
ISBN-13: | 9783319312125 |
ISBN-10: | 331931212X |
Sprache: | Englisch |
Ausstattung / Beilage: | HC runder Rücken kaschiert |
Einband: | Gebunden |
Autor: |
Gitlin, Michael
Bauer, Michael |
Auflage: | 1st ed. 2016 |
Hersteller: |
Springer Nature Switzerland
Springer International Publishing Springer International Publishing AG |
Verantwortliche Person für die EU: | Books on Demand GmbH, In de Tarpen 42, D-22848 Norderstedt, info@bod.de |
Maße: | 241 x 160 x 15 mm |
Von/Mit: | Michael Gitlin (u. a.) |
Erscheinungsdatum: | 27.05.2016 |
Gewicht: | 0,461 kg |